Accelerating Transplant Denial Appeal Automation

The Unique Challenges of Transplant Denials

Transplant prior authorizations are inherently complex, covering a continuum from pre-transplant evaluation workups to the transplant procedure itself, and ongoing post-transplant immunosuppressants and infusion meds. Denials in this specialty often hinge on detailed clinical criteria, medical necessity, and extensive documentation, making manual appeal processes particularly resource-intensive and prone to error.

High-Volume Transplant PA Categories Prone to Denials

• Transplant evaluations (e.g., advanced imaging, genetic testing, multi-specialty consultations)
• High-cost immunosuppressants (e.g., tacrolimus, mycophenolate mofetil, sirolimus)
• Infusion medications critical for pre- or post-transplant care (e.g., IVIG, anti-rejection therapies)
• Surgical procedures for solid organ transplantation (e.g., kidney, liver, heart, lung)
• Advanced diagnostic tests for monitoring organ function or rejection markers

Klivira's Automated Appeal Workflow for Transplant Centers

Klivira transforms the manual, error-prone transplant denial appeal process into an intelligent, automated workflow. Leveraging normalized CARC/RARC taxonomy (src: x12-carc-rarc) and a comprehensive payer-policy library, our system classifies denials, selects the correct appeal pathway, and accelerates the entire process from evidence gathering to submission.

Key Features for Transplant Denial Appeal Automation

• Denial Classification & Pathway Selection: Automatically routes denials based on payer and reason, ensuring the correct first-level, second-level, or peer-to-peer pathway is invoked, adhering to timely-filing windows.
• FHIR-based Clinical Evidence Extraction: Dynamically pulls additional clinical documentation from the EMR (e.g., updated labs, imaging, progress notes, peer-reviewed literature for off-label use) to address specific denial reasons.
• Automated Appeal Letter Generation: Composes payer-template-based appeal letters addressing denial codes, pre-populating with relevant clinical evidence, and drafting clinician-reviewable letters for clinical-necessity cases.
• Multi-Channel Appeal Submission: Submits appeals via the payer's preferred channel—portal, fax, or Da Vinci PAS-conformant resubmission—and provides automated status tracking with escalation rules.
• Outcome Capture & Feedback: Records appeal outcomes in the EMR (as DocumentReference and Communication resources) and uses success patterns to refine upstream PA submissions.

Seamless EMR Integration and Payer Connectivity

Klivira integrates with major EMR systems via SMART on FHIR, allowing for real-time data exchange of patient demographics, clinical notes, lab results, and medication lists crucial for transplant appeals. Our platform connects to a vast network of payer portals and utilizes X12 278 and NCPDP SCRIPT standards where applicable, ensuring comprehensive coverage for transplant-specific prior authorizations and appeals.

Driving Efficiency and Patient Access in Transplant Care

By automating transplant denial appeals, Klivira reduces the significant rework costs identified by the CAQH Index (src: caqh-index), minimizes timely-filing breaches, and improves appeal success rates. This operational efficiency translates directly into faster access to life-saving transplant evaluations, procedures, and critical immunosuppressant therapies, ultimately enhancing patient outcomes and financial stability for transplant centers.